Cipla won the landmark Roche v Cipla Litigation
8th September, 2012 - 10:46 am
Categories:
IP Practice in India
News & Updates
Pharma/Biotech Patent Litigations
0 Comments
Indian Generic manufacturer Cipla has won the landmark Roche v. Cipla Patent Infringement case in the Delhi High Court over Cipla’s Generic version of Anti-cancer Drug Erlotinib. The case is the first Patent Litigation in India post India’s 2005 Product Patent Regime which included public interest and pricing issues in addition to India’s Section 3d … Continue reading Cipla won the landmark Roche v Cipla Litigation
Read more »Inventors, All Technologies Aren’t Worth Billions
31st July, 2011 - 6:23 pm
Categories:
Hi Tech Patent Commercialisation
Patent Commercialisation
Pharma- biotech- Patent Commercialisation
0 Comments
Working in the IP/Technology Commercialization and Out-Licensing domain makes you assess and evaluate commercial viability of numerous IP backed inventions across technology domains. Apart from learning about and assessing new technologies, we also tend to learn quite of lot about Inventors mindset, specifically about their perspective of their own inventions. This article relates to our … Continue reading Inventors, All Technologies Aren’t Worth Billions
Read more »Roche’s Struggle Over its Patents in India – Two suits, Two oppositions
27th July, 2010 - 4:47 am
Categories:
Patent Litigation
Pharma/Biotech Patent Litigations
2 Comments
The struggle between innovator pharmaceutical companies (mostly in the Western world) and developing world Generic companies has been lately played out in India and especially for the last 2-3 years in the form of litigations and oppositions. Here I would be discussing the specific case of Roche (a Swiss Pharma Company) showcasing its journey of … Continue reading Roche’s Struggle Over its Patents in India – Two suits, Two oppositions
Read more »